Functionally, TRIM25 bolstered tumor cell survival during ER stress mainly through directly targeting the Keap1 protein to ubiquitination-mediated proteasomal degradation, thereby promoting Nrf2 to the nucleus to activate the expression of Nrf2-responsive target genes of the anti-oxidative cell response (Figure 5) [104]. The gene discussed is TRIM25; the disease is neoplasm.